Replies to post #197442 on NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

That’s easy. They had the ability with the adaptive design to conduct the statistical analysis before ALL the treatments were done. They clearly opted against doing so and so yes, it’s very clear to me they opted to wait until the end of trial.